# Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

> **NCT06692894** · — · RECRUITING · sponsor: **University of Vermont** · enrollment: 30 (estimated)

## Conditions studied

- Myelodysplastic Syndromes, Adult

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT06692894
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-05
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06692894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06692894, "Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06692894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*